Trop2Fab-DOX ADC

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameTrop2Fab-DOX ADC
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Trop-2Topoisomerase II inhibitors
TargetsTumor-associated calcium signal transducer 2Topoisomerase II
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Province Geriatric InstituteHuadong Medical Institute of Biotechniques
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medical Institute of BiotechniquesJiangsu Province Geriatric Institute
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A